证券研究报告 | 2025年7月13日 请务必阅读正文之后的免责声明及其项下所有内容 ➢ 根据马拉松资本《资本回报：穿越资本周期的投资》的观点，资本周期方法的关键是要理解一个行业内配置的资本数 量的变动将如何影响未来回报，换句话说，也就是观察供给方面的变化如何影响公司的竞争态势。传统价值/成长的二 分法存在问题。表现超过市场预期的公司有理由获得更高的估值。相比于分析供给，大部分投资者在分析需求上花更 多时间，但预测需求比预测供给更难。供给变动驱动行业盈利性，股价常常未能预见供给侧的变动。 ➢ 在企业生命周期的不同状态下，行业集中度呈现倒U型分布，先经历了供给侧的优化和高度竞争后的出清，随后集中度 走高形成垄断寡头格局，盈利也经历了类似的对称性分布。分红方面，随着企业从复苏期-增长期-竞争期-成熟期的演 化，股息率中枢不断走高。 ➢ 按照相对回报和绝对回报在历史 8 个阶段回报定位，根据一季报数据筛选得出的优势阶段行业和重点观察行业，按照 开支-盈利水平按照三季报的指引来定位，则可以发现行业集中度呈现 U 型分布。当前处于推荐阶段的二级行业有养殖 业、动物保健Ⅱ、元件、消费电子、通信服务、广告营销、电视广播Ⅱ、 ...

证券代码：002688 证券简称：金河生物 金河生物科技股份有限公司投资者关系活动记录表 编号：2025-004 | | □特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活动 | □媒体采访  业绩说明会 | | 类别 | □新闻发布会□路演活动 | | | □现场参观 | | | □其他（请文字说明其他活动内容） | | 参与单位名称及 | 参与 2025 年内蒙古辖区上市公司投资者网上集体接待日活动的 | | 人员姓名 | 投资者 | | 时间 | 2025 年 7 月 11 日（周五）下午 16:00-18:00 | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | 采用网络远程的方式召开业绩说明会 | | 上市公司接待人 | 董事、总经理谢昌贤先生 | | 员姓名 | 董事、董事会秘书路漫漫先生 | | | 财务总监牛有山先生 | | | Q1:请问公司赤藓糖醇项目后期拟继续进行吗？有股友建议转产 | | | 阿洛酮糖可行性如何？ | | | A1：您好！该项目公司目前尚未安排建设，目前无相关信息可提 | | | 供， ...

证券代码：603566 证券简称：普莱柯 公告编号：2025-027 普莱柯生物工程股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要提示： ? 业绩预告适用情形：实现盈利，且净利润与上年同期相比上升 50%以上。 四、风险提示 的净利润为 10,700.00 万元到 12,200.00 万元，与上年同期相比，增加 3,305.37 万元到 4,805.37 万元，同比上升 44.70%到 64.98%。 预计 2025 年半年度实现归属于母公司所有者的扣除非经常性损益的净利润 为 9,300.00 万元到 10,600.00 万元，与上年同期相比，增加 2,659.65 万元到 3,959.65 万元，同比上升 40.05%到 59.63%。 二、上年同期经营业绩和财务状况 （一）归属于母公司所有者的净利润：7,394.63 万元；归属于母公司所有者 的扣除非经常性损益的净利润：6,640.35 万元。 （二）每股收益：0.21 元/股。 三、本期业绩预增的主要原因 联疫苗等新产品的上市为公司贡献了新的业绩增 ...

（三）本次激励计划首次授予第二个解除限售期及预留授予第一个解除限售 期的激励对象具备《公司法》等法律法规、规范性文件及《公司章程》规定的任 职资格，符合《管理办法》等文件及《激励计划》规定的激励对象条件，符合《激 励计划》规定的激励对象范围，其作为本次可解除限售的激励对象主体资格合法、 有效。 综上所述，监事会认为，根据《上市公司股权激励管理办法》《金河生物科 技股份有限公司 2023 年限制性股票激励计划（草案修订稿）》和《2023 年限制 性股票激励计划实施考核管理办法（修订稿）》的有关规定，公司 2023 年限制 性股票激励计划首次授予部分第二个解除限售期及预留授予部分第一个解除限 售期解除限售条件已经成就。监事会对符合解除限售资格条件的 70 名首次授予 激励对象及 11 名预留授予激励对象进行了核查，认为上述激励对象的可解除限 售限制性股票的数量与其在考核年度内的考核结果相符，其作为本次可解除限售 的激励对象主体资格合法、有效，审议程序合法、合规。监事会同意公司按规定 为符合条件的 70 名首次授予激励对象在首次授予部分第二个解除限售期届满后 办理 4,326,000 股限制性股票的解除限售相关事宜 ...

Core Viewpoint - The legal opinion letter from Beijing Zhonglun (Shanghai) Law Firm confirms the completion of the second unlock period for the initial grant of restricted stock and the first unlock period for reserved grants under the 2023 Restricted Stock Incentive Plan of Jinhe Biotechnology Co., Ltd, along with the repurchase and cancellation of certain restricted stocks and adjustments to the repurchase price [1][2][22]. Group 1: Unlock Conditions and Achievements - The second unlock period for the initial grant of restricted stocks is set to be 24 months after the registration completion date, which was completed on July 7, 2023 [13][14]. - The first unlock period for reserved grants is 12 months after the registration completion date, which was completed on December 28, 2023 [14]. - The company has met the performance assessment requirements for the unlock conditions, with a net profit growth rate of 88.29% in 2024, exceeding the required 78% [17][18]. Group 2: Repurchase and Price Adjustment - The company plans to repurchase and cancel a total of 2,100,000 shares of restricted stock due to the departure of certain incentive targets and performance failures [21][22]. - The adjusted repurchase price for the restricted stocks is set at 2.29 yuan per share, following a cash dividend distribution of 1.00 yuan per 10 shares [19][22]. - The repurchase will be funded by the company's own funds, and the repurchase reasons, quantity, price, and funding sources comply with relevant regulations [22].

行 业 及 产 业 盛瀚 A0230522080006 shenghan@swsresearch.com 研究支持 农林牧渔 2025 年 07 月 06 日 行 业 研 究 / 行 业 点 评 相关研究 证 券 研 究 报 告 证券分析师 朱珺逸 A0230521080004 zhujy@swsresearch.com 胡静航 A0230524090002 hujh@swsresearch.com 联系人 朱珺逸 (8621)23297818× zhujy@swsresearch.com 猪价创春节后新高，关注产能与库存行为变化 看好 ——农林牧渔周观点（2025.6.30-2025.7.6） 本期投资提示： 请务必仔细阅读正文之后的各项信息披露与声明 本研究报告仅通过邮件提供给 中庚基金 使用。1 - ⚫ 本周申万农林牧渔指数上涨 2.5%，沪深 300 上涨 1.5%。个股涨幅前五名：辉隆股份（-2.5%）、晓鸣股份（4.8%）、神 农集团（4.0%）、海利生物（1.7%）、牧原股份（4.9%），跌幅前五名：安德利（-1.0%）、ST 天山（8.2%）、普莱柯 （1.1%）、国投中鲁（0.0%）、保龄宝 ...

行 业 及 产 业 农林牧渔 行 业 研 究 / 行 业 点 证券分析师 盛瀚 A0230522080006 shenghan@swsresearch.com 研究支持 朱珺逸 A0230521080004 zhujy@swsresearch.com 胡静航 A0230524090002 hujh@swsresearch.com 联系人 盛瀚 (8621)23297818× shenghan@swsresearch.com 本研究报告仅通过邮件提供给 中庚基金 使用。1 2025 年 07 月 05 日 养殖盈利兑现，"后周期"景气上行，宠物 食品龙头延续较快增长 看好 ——农林牧渔行业 2025 年中报前瞻 本期投资提示： 证 券 研 究 报 告 请务必仔细阅读正文之后的各项信息披露与声明 评 - ⚫ 生猪养殖盈利兑现，禽养殖景气分化，"后周期"景气上行，宠物食品龙头延续高增。2025 年上半年，预计农林牧渔行业整体盈利明显改善，根据我们跟踪的 22 家上市企业来看，预 计生猪养殖、饲料业、宠物食品、动物保健表现较好，从单 Q2 业绩增速来看，预计以下公 司表现较好（业绩增速超过 30%）：晓鸣股份（扭亏为 ...

宠物医药：突破从 0 到 1，何以从 1 至 1020260629 摘要 中国宠物药品市场增长迅速，年复合增长率达 22%，需求具有刚性，贯 穿宠物生命周期。宠物老龄化加速，七岁以上老年犬占比显著提升，推 动老年病用药需求增加，养宠意识提升也增强了消费意愿。 宠物临床用药面临供给瓶颈，尤其老年病用药紧缺，长期依赖进口。行 业探索人药转化，发布《宠物临床急需使用的人用药品目录》以缓解供 需矛盾，并加速研发创新，突破慢性疾病、肿瘤等特效药研发。 国产企业在核心疫苗领域取得进展，如猫三联疫苗。瑞普生物推出国内 首个获批上市的猫三联疫苗瑞苗舒，截至 2025 年 6 月，共有 11 款国 产猫三联疫苗上市，逐步打破外资垄断。 宠物疫苗市场空间广阔，国产替代加速。国内强制免疫狂犬疫苗市场份 额约为 30-40 亿元，猫三联和犬联两种核心疫苗分别约 20 亿元左右规 模。国产企业逐步突破，形成技术集权效应。 国产猫三联疫苗在毒株匹配性和价格方面具有优势。国产疫苗毒株更适 合国内猫咪，且价格通常比进口疫苗低 20%左右，推动国产替代。 Q&A 当前我国宠物药品市场的主要特征是什么？ 我国宠物药品市场的主要特征包括需求爆发和 ...

Group 1 - The Shanghai Composite Index has recently surpassed the annual high set on March 18, 2025, and is approaching the high from October 8, 2024, indicating a significant market movement [1] - There is a noticeable divergence among various sectors, with banking, agriculture, personal care, military, chemical, transportation, and petrochemical industries showing a higher proportion of stocks exceeding their March 18, 2025 closing prices [1] - Conversely, sectors such as steel, electronics, home appliances, telecommunications, computers, and electrical equipment have a lower proportion of stocks exceeding their March 18, 2025 levels [1] Group 2 - In the secondary industry analysis, financial (banking, insurance, diversified finance), military (naval equipment, ground weaponry), agriculture (animal health, agricultural products, planting, feed), precious metals, personal care products, and chemical pharmaceuticals show a higher proportion of stocks exceeding their March 18, 2025 closing prices [4] - Sectors like home appliances, electrical equipment, TMT (television broadcasting, communication services, consumer electronics, semiconductors, optical electronics), general steel, and machinery (engineering machinery, automation equipment) have a lower proportion of stocks exceeding their March 18, 2025 levels [4] - Comparing to the October 8, 2024 closing prices, banking, motorcycles, military (ground weaponry, aerospace equipment), chemicals (plastics, non-metallic materials), and new consumption (entertainment products, personal care products, retail, accessories) show a higher proportion of stocks exceeding their previous levels [4]

Group 1: Company Announcements - Jingce Electronics' subsidiary signed sales contracts for semiconductor measurement equipment totaling 113 million yuan [1] - Zhifei Biological plans to issue company bonds not exceeding 6 billion yuan for technology innovation and working capital [1] - Rijiu Optoelectronics' subsidiary plans to invest 822 million yuan in a functional film project with an annual production capacity of 6 million square meters [1] - Huiyun Titanium Industry's subsidiary intends to acquire a 53.125% stake in Chenshang Mining for 30.6 million yuan and increase capital by 32.4 million yuan [2] - Hongte Technology plans to raise up to 650 million yuan through a rights issue for various projects and working capital [2] - Jincheng Pharmaceutical's subsidiary received FDA approval for the active pharmaceutical ingredient Posaconazole [4] - Kairun Co. plans to reduce its shareholding by up to 2% due to personal funding needs [5] - Rundou Co. passed an FDA inspection for nine active pharmaceutical ingredients [6] - Sanyou Lianzhong's shareholders plan to reduce their holdings by up to 3% due to funding needs [7] - *ST Yazhen's stock was suspended for trading due to a significant price increase of 29.43% [9] - Online and Offline plans to change control with a share transfer agreement, leading to a new controlling shareholder [10] - Dazhong Mining intends to purchase office space from an affiliate for 50.17 million yuan [11] - Suzhou Bank's major shareholder increased its stake by 856 million yuan [12] - *ST Fanli's subsidiary plans to acquire a 60% stake in Guangzhou Fengteng for up to 28.8 million yuan [14] - Hengmingda's major shareholders plan to reduce their holdings by up to 3.15% [16] - Guomai Technology's shareholder plans to reduce its stake by up to 1% due to funding needs [17] - ST Bailin's stock will change its name to Guizhou Bailin and remove risk warnings [17] - *ST Xianfeng's stock will change its name to Xianfeng Holdings and remove risk warnings [18] - Maiwei Bio signed an exclusive licensing agreement with CALICO for a monoclonal antibody, receiving an upfront payment of 25 million USD [19] - Maiwei Bio signed a technology licensing agreement with Qilu Pharmaceutical for a new drug project, with a total payment of up to 500 million yuan [21] - Maiwei Bio plans to repurchase shares worth between 25 million and 50 million yuan [22] - Mengwang Technology plans to acquire 100% of Bicheng Digital for 1.28 billion yuan to expand its e-commerce services [22] Group 2: Industry Overview - Jingce Electronics operates in the mechanical equipment sector, focusing on measurement systems for displays, semiconductors, and new energy [1] - Zhifei Biological is in the pharmaceutical sector, specializing in vaccine and biological product development [1] - Rijiu Optoelectronics is part of the electronics industry, focusing on touch display materials and functional films [1][2] - Huiyun Titanium Industry operates in the basic chemicals sector, focusing on titanium dioxide products [2] - Hongte Technology is in the automotive industry, specializing in aluminum alloy precision die-casting for automotive components [2][3] - Jincheng Pharmaceutical is in the pharmaceutical sector, focusing on chemical pharmaceuticals and active ingredients [4] - Rundou Co. operates in the pharmaceutical sector, focusing on chemical drug formulations and raw materials [6] - Sanyou Lianzhong is in the electrical equipment sector, specializing in relays and transformers [7] - *ST Yazhen operates in the light industry, focusing on high-end furniture products [9] - Online and Offline is in the communication sector, focusing on communication services and applications [10] - Dazhong Mining operates in the steel industry, focusing on iron ore mining and processing [11] - Suzhou Bank is a city commercial bank, providing various banking services [12] - *ST Fanli operates in the media sector, focusing on online advertising and marketing services [14] - Hengmingda is in the electronics sector, focusing on precision components for consumer electronics [16] - Guomai Technology operates in the education sector, focusing on IoT technology services [17] - ST Bailin is in the energy sector, providing engineering consulting and smart factory solutions [17] - *ST Xianfeng operates in the animal health sector, focusing on vaccines and animal nutrition [18] - Maiwei Bio is in the pharmaceutical sector, focusing on biopharmaceuticals [19][21][22] - Mengwang Technology operates in the communication sector, focusing on cloud platform services [22]